Breast cancer after bilateral risk-reducing mastectomy

Skytte A‐B, Crüger D, Gerster M, Lænkholm A‐V, Lang C, Brøndum‐Nielsen K, Andersen MK, Sunde L, Kølvraa S, Gerdes A‐M. Breast cancer after bilateral risk‐reducing mastectomy. This study aims to evaluate the incidence of breast cancer after risk‐reducing mastectomy (RRM) in healthy BRCA mutation carr...

Full description

Saved in:
Bibliographic Details
Published inClinical genetics Vol. 79; no. 5; pp. 431 - 437
Main Authors Skytte, A-B, Crüger, D, Gerster, M, Lænkholm, A-V, Lang, C, Brøndum-Nielsen, K, Andersen, MK, Sunde, L, Kølvraa, S, Gerdes, A-M
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.05.2011
Wiley-Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Skytte A‐B, Crüger D, Gerster M, Lænkholm A‐V, Lang C, Brøndum‐Nielsen K, Andersen MK, Sunde L, Kølvraa S, Gerdes A‐M. Breast cancer after bilateral risk‐reducing mastectomy. This study aims to evaluate the incidence of breast cancer after risk‐reducing mastectomy (RRM) in healthy BRCA mutation carriers. This study is a long‐term follow‐up of 307 BRCA mutation carriers of whom 96 chose RRM. None of the study participants had a previous history of breast or ovarian cancer nor had they undergone RRM or risk‐reducing bilateral salpingo‐oophorectomy (BSO) prior to the time of BRCA testing. The annual incidence of post‐mastectomy breast cancer was 0.8% compared with 1.7% in the non‐operated group. Implications of these findings in relation to genetic counseling and future management are discussed.
Bibliography:ArticleID:CGE1604
istex:C8324683E6280079482331115B1E22935E6A6570
ark:/67375/WNG-Z7Q4WD92-3
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0009-9163
1399-0004
DOI:10.1111/j.1399-0004.2010.01604.x